Fig. 7From: circACTR2 attenuates gemcitabine chemoresiatance in pancreatic cancer through PTEN mediated PI3K/AKT signaling pathwayProposition of a model in which circACTR2 acts as a sponge for miR-221-3p to reduce PC GEM resistance by regulating the PTEN/PI3K/AKT signaling pathwayBack to article page